Cantor Equity Partners VII Inc

Aktienanalyse zu Cantor Equity Partners VII Inc (CAES)

$10.100

+0.010 (+0.10%)Zum Schluss

Loading chart…
High
10.100
Open
10.095
VWAP
10.10
Vol
7.11K
Mkt Cap
Low
10.095
Amount
71.75K
EV/EBITDA, TTM
0.00

Cantor Equity Partners VII, Inc. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has conducted no operations and has generated no revenues.

AI analysis of Cantor Equity Partners VII Inc (CAES)

hold

Currently, Cantor Equity Partners VII Inc (CAES) is not a strong buy due to its negative earnings and high debt levels. The stock has a current price of 10.11, with a forward P/E ratio of 0, indicating uncertainty in future earnings. Additionally, the current ratio has improved to 7.07 in Q2 2026, suggesting better liquidity, but the overall financial health remains concerning with a total equity of -90265.00 USD. The RSI is at 65.855, indicating that the stock is nearing overbought territory, which could lead to a price correction.

Bewertungskennzahlen

The current forward P/E ratio for Cantor Equity Partners VII Inc (CAES) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

Whales holding CAES

C

Cantor Fitzgerald Asset Management

+ HoldingCAES

-6.99%

3M Return

CAES FAQ — answered by Alphio AI

Cantor Equity Partners VII, Inc. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has conducted no operations and has generated no revenues. It operates in the Financials sector.

Currently, Cantor Equity Partners VII Inc (CAES) is not a strong buy due to its negative earnings and high debt levels. The stock has a current price of 10.11, with a forward P/E ratio of 0, indicating uncertainty in future earnings. Additionally, the current ratio has improved to 7.07 in Q2 2026, suggesting better liquidity, but the overall financial health remains concerning with a total equity of -90265.00 USD. The RSI is at 65.855, indicating that the stock is nearing overbought territory, which could lead to a price correction.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten